Viking Therapeutics, Inc. (VKTX) closed the latest trading day at $23.91, indicating a -0.99% change from the previous session's end. The stock's change was less than the S&P 500's daily gain of 0.38% ...

Viking Mines (ASX:VKA) has announced the discovery of another gold anomaly, extending over 300 meters, at its Bifrost Project ...

Last fall, a Swedish man spotted something in a marsh on Oland, Sweden’s second-largest island. At first, he thought the ...

Two major Viking Age museums are the highlight of a visit to Ribe, the oldest town in Denmark and a must-visit on any tour of ...

Öland was once a key trading post for Sweden, especially during the Viking age. The country’s second-largest island sits off ...

Viking (NYSE:VIK – Get Free Report) is one of 30 public companies in the “Water transportation” industry, but how does it weigh in compared to its rivals? We will compare Viking to similar businesses ...

Viking Therapeutics ( VKTX -0.30%) is a promising growth stock with a strong GLP-1 drug candidate in VK2735, which may ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Zentalis Pharmaceuticals (ZNTL – Research ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Viking Therapeutics (VKTX) announced the completion of subject enrollment in its Phase 2 clinical trial of the oral tablet formulation of ...

In the upcoming Eliteserien match, Valerenga will face off against Viking in a captivating showdown that promises to ignite the passions of football fans. As both teams prepare to clash, it’s ...